Japan’s Development Bank has made a strategic move into the UK’s life sciences sector by investing in 4Bio Capital, a UK-based venture fund. This significant investment aims to raise £164 million to £246 for 4Bio’s third fund, which focuses on pioneering cell and gene therapy treatments.

This investment marks Japan’s expanding interest in the life sciences field in the UK and is a testament to the sector’s global potential and collaborative opportunities.